620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion

Eugene Shenderov, G.H.G. Mallesara, Piotr J. Wysocki, Wen Xu, Rodryg Ramlau, Andrew Weickhardt, Jakub Żołnierek, Alexander I. Spira, Anthony M. Joshua, John D. Powderly, Emmanuel S. Antonarakis, S. Jang, Jeanny B. Aragon‐Ching, Jiayu Shen, Channing J. Paller, Nicholas J. Vogelzang, Kirsten Leu, Javier Cortés, Chet Bohac, Iwona Ługowska